论文部分内容阅读
目的 :观察晶珠肝泰舒胶囊治疗慢性乙型肝炎的疗效 ,方法 :选我院2000年6月至9月收住院的45例慢性乙型肝炎(中度或重度 )患者。患者均有明显的消化道症状及乏力等。治疗前全部病例血清HBVDNA阳性 ,其中HBsAg 阳性者35例。无其它肝炎病毒重叠感染。全部病例均接受晶珠肝泰舒胶囊治疗。采用2粒/次 ,3次/日 ,治疗一疗程 (三个月 )并观察临床症状、体征、化验检查及副反应。结果 :总有效率93 3 % ,HBVDNA阴转率10 % ,HBeAg 阴转率36 3 % ,病例均未见明显的副反应。结论 :晶珠肝泰舒具有明显的护肝作用 ,且有一定的抗病毒作用 ,其口服给药方便、廉价 ,值得进一步推广。
Objective: To observe the therapeutic effect of Jingzhu Giantai Capsule on chronic hepatitis B. Methods: Forty-five patients with chronic hepatitis B (moderate or severe) were admitted to our hospital from June to September in 2000. Patients have obvious gastrointestinal symptoms and fatigue. Serum HBVDNA was positive in all cases before treatment, of which 35 were HBsAg positive. No other hepatitis virus overlap infection. All patients received crystal beads liver Taishu capsule treatment. Using 2 capsules / time, 3 times / day, a course of treatment (three months) and observe the clinical symptoms, signs, laboratory tests and side effects. Results: The total effective rate 93 3%, HBVDNA negative conversion rate 10%, HBeAg negative conversion rate 36 3%, no significant adverse reactions in patients. Conclusion: Gemcitabine has obvious hepatoprotective effects and certain antiviral effects. Its oral administration is convenient and cheap, which is worth further promotion.